Discover
CLOV
Clover Health Investments, Corp.
4.39
7 x 4.38
7 x 4.44
bid
ask
-
0.18
3.94%
1735 @ 04:00 PM
4.44 +0.05 (1.14%)
| Ytd | 86.81% | |
| 1y | 77.73% |
4.34
day range
4.59
1.58
52 week range
5.59
| Open | 4.55 | Prev Close | 4.57 | Low | 4.34 | High | 4.59 | Mkt Cap | 2.28B |
| Vol | 0.00 | Avg Vol | 7.31M | EPS | 0.04 | P/E | 102.95 | Forward P/E | 30.47 |
| Beta | 2.48 | Short Ratio | 4.12 | Inst. Own | 30.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.61 | 200-d Avg | 3.03 | 1yr Est | 5.17 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-11-04 | 2026-09 | 0 | N/A | N/A | N/A |
| 2026-08-05 | 2026-06 | 0.04 | 0.05 | 0.01 | 29.40% |
| 2026-05-06 | 2026-03 | 0.07 | 0.07 | N/A | N/A |
| 2026-02-26 | 2025-12 | -0.1 | -0.05 | 0.05 | 51.04% |
| 2025-11-04 | 2025-09 | 0.02 | -0.05 | -0.07 | -350.00% |
| 2025-08-05 | 2025-06 | 0.03 | 0.03 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-08-06 | UBS | Upgrade | Neutral | Neutral |
| 2026-07-21 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-06-11 | UBS | Upgrade | Neutral | Neutral |
| 2026-06-04 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-05 | Leerink Partners | Upgrade | Market Perform | Market Perform |
Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-01-05 | CLINTON CHELSEA | Director | 602.81K | Stock Award(Grant) |
| 2026-01-06 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.86M | Conversion of Exercise of derivative security |
| 2026-01-05 | KOUZOUKAS DEMETRIOS L | Director | 605.98K | Stock Award(Grant) |
| 2025-05-18 | KUIPERS PETER J | Chief Financial Officer | 6.35M | Stock Award(Grant) |
| 2026-05-12 | PRIEST BRADY PATRICK | Officer | 2.04M | Sale |
| 2026-07-16 | REYNOSO JAMIE L. | Officer | 2.81M | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-06-29 | Blackrock Inc. | 35.11M | 154.12M | 8.06% |
| 2026-03-30 | Vanguard Capital Management LLC | 16.98M | 74.55M | 3.90% |
| 2026-06-29 | State Street Corporation | 10.18M | 44.69M | 2.34% |
| 2026-03-30 | Geode Capital Management, LLC | 10.06M | 44.14M | 2.31% |
| 2026-03-30 | Charles Schwab Investment Management, Inc. | 5.30M | 23.27M | 1.22% |
| 2026-03-30 | Vanguard Portfolio Management LLC | 3.70M | 16.23M | 0.85% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 12.06M | 52.96M | 2.77% |
| 2026-06-29 | iShares Trust-iShares Russell 2000 ETF | 10.86M | 47.69M | 2.49% |
| 2026-03-30 | VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 4.46M | 19.59M | 1.02% |
| 2026-05-30 | Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 4.08M | 17.92M | 0.94% |
| 2026-06-29 | iShares Trust-iShares Russell 2000 Growth ETF | 3.87M | 16.99M | 0.89% |
| 2026-05-30 | VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 2.10M | 9.22M | 0.48% |
Dividend
| Dividend | Date |
|---|---|
| 0.1 | 2021-08-23 |